Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO914 | Smilacis glabrae rhixoma | NA | NA | NA | TCMSP* | |||
NPO3912 | Areca catechu | Species | Arecaceae | Eukaryota | TCMSP* | |||
NPO9328 | Dioscoreaebulbiferae | NA | NA | NA | TCMSP* | |||
NPO14715 | Trollius chinensis | Species | Ranunculaceae | Eukaryota | TCMSP* | |||
NPO6805 | Cortex hibisci | NA | NA | NA | TCMSP* | |||
NPO24260 | Sapindi mukorossiperic arpium | NA | NA | NA | TCMSP* | |||
NPO27178 | Ilicis purpureae folium | NA | NA | NA | TCMSP* | |||
NPO29547 | Broussonetiae fructus | NA | NA | NA | TCMSP* | |||
NPO27942 | Herba pyrolae | NA | NA | NA | TCMSP* | |||
NPO29551 | Mori fructus | NA | NA | NA | TCMSP* | |||
NPO6444 | Humulus scandens | Species | Cannabaceae | Eukaryota | TCMSP* | |||
NPO14886 | Radix aconiti kusnezoffii | Species | Lymnaeidae | Eukaryota | TCMSP* | |||
NPO8014 | Sterculiae lychnophorae semen | NA | NA | NA | TCMSP* | |||
NPO29586 | Gleditsiae fructus abnormalis | NA | NA | NA | TCMSP* | |||
NPO29695 | Gleditsiae spina | NA | NA | NA | TCMSP* | |||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TM-MC* | |||
NPO26650 | Terminalia chebula | Species | Combretaceae | Eukaryota | TM-MC* | |||
NPO20553 | Zingiber officinale | Species | Zingiberaceae | Eukaryota | TM-MC* | |||
NPO26371 | Sorghum bicolor | Species | Poaceae | Eukaryota | TCMID* | |||
NPO3846 | Melia indica | Species | Meliaceae | Eukaryota | TCMID* | |||
NPO21331 | Syzygium samarangense | Species | Myrtaceae | Eukaryota | UNPD* | |||
NPO21454 | Iodes cirrhosa | Species | Icacinaceae | Eukaryota | UNPD* | |||
NPO18024 | Acacia pruinosa | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO14318 | Lespedeza davidii | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO28293 | Aegilops geniculata | Species | Poaceae | Eukaryota | UNPD* | |||
NPO20444 | Corticium caeruleum | Species | Plakinidae | Eukaryota | UNPD* | |||
NPO18228 | Cycas beddomei | Species | Cycadaceae | Eukaryota | UNPD* | |||
NPO29553 | Hordei fructus germinatus | NA | NA | NA | TCMSP* | |||
NPO19676 | Lunulatae herba | NA | NA | NA | TCMSP* | |||
NPO15557 | Menispermi rhizoma | NA | NA | NA | TCMSP* | |||
NPO5800 | Radix salviae | Species | Lymnaeidae | Eukaryota | TCMSP* | |||
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | TCMSP* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | ED50 | = | 2.9 | nM | 12039563 | |
NPT2 | Others | Unspecified | Inhibition | = | 74 | % | 2478667 | |
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | < | 50 | ug/ml | 1710653 |
NPT2 | Others | Unspecified | IC50 | = | 29 | nM | 1324983 | |
NPT2 | Others | Unspecified | IC50 | = | 410 | nM | 1324983 | |
NPT45 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens | Potency | = | 5011.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | > | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 12995.3 | nM | PubChem BioAssay data set | |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 100 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 707.9 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 95.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 25929 | nM | PubChem BioAssay data set | ||
NPT4 | Individual Protein | Large T antigen | Simian virus 40 | IC50 | < | 160 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 1412.5 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 794.3 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 20587.8 | nM | PubChem BioAssay data set | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 75900 | nM | 21669522 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 32800 | nM | 21669522 |
NPT1063 | Individual Protein | Carbonic anhydrase VI | Homo sapiens | Ki | = | 17800 | nM | 21669522 |
NPT2243 | Individual Protein | Carbonic anhydrase | Dicentrarchus labrax | Ki | = | 9410 | nM | 21669522 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 9285 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 11689.1 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 23934.1 | nM | PubChem BioAssay data set | |
NPT2966 | Individual Protein | T-complex protein 1 subunit beta | Macaaca fascicularis | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT68 | Individual Protein | Aldose reductase | Rattus norvegicus | IC50 | = | 346 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | IC50 | = | 1335 | nM | DrugMatrix in vitro pharmacology data | |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 919 | nM | DrugMatrix in vitro pharmacology data |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | IC50 | = | 4607.4 | nM | DrugMatrix in vitro pharmacology data |
NPT253 | Individual Protein | HMG-CoA reductase | Homo sapiens | IC50 | = | 3127 | nM | DrugMatrix in vitro pharmacology data |
NPT255 | Individual Protein | Leukotriene C4 synthase | Cavia porcellus | IC50 | = | 2715 | nM | DrugMatrix in vitro pharmacology data |
NPT257 | Individual Protein | Arachidonate 15-lipoxygenase | Oryctolagus cuniculus | IC50 | = | 268 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | IC50 | = | 714 | nM | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | IC50 | = | 1043 | nM | DrugMatrix in vitro pharmacology data | |
NPT273 | Individual Protein | Phosphodiesterase 5A | Homo sapiens | IC50 | = | 4703 | nM | DrugMatrix in vitro pharmacology data |
NPT281 | Individual Protein | MAP kinase ERK1 | Homo sapiens | IC50 | = | 4052 | nM | DrugMatrix in vitro pharmacology data |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | IC50 | = | 185 | nM | DrugMatrix in vitro pharmacology data |
NPT283 | Individual Protein | MAP kinase p38 alpha | Homo sapiens | IC50 | = | 375 | nM | DrugMatrix in vitro pharmacology data |
NPT14 | Individual Protein | Tyrosine-protein kinase FYN | Homo sapiens | IC50 | = | 22 | nM | DrugMatrix in vitro pharmacology data |
NPT13 | Individual Protein | Tyrosine-protein kinase LCK | Homo sapiens | IC50 | = | 79 | nM | DrugMatrix in vitro pharmacology data |
NPT300 | Individual Protein | Thromboxane-A synthase | Homo sapiens | IC50 | = | 325 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | 36588.1 | nM | PubChem BioAssay data set | |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | 17.6 | % | 21805983 |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | 3.2 | % | 21805983 |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | 0.1 | nM | 21805983 |
NPT2 | Others | Unspecified | IC50 | > | 300000 | nM | 23394144 | |
NPT2 | Others | Unspecified | Potency | 19952.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 25118.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4610.9 | nM | PubChem BioAssay data set | ||
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4217.2 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Inhibition | = | 76.31 | % | 23434134 | |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | IC50 | = | 4168.69 | nM | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Ki | = | 3230 | nM | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 18.66 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | IC50 | = | 2630.27 | nM | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Ki | = | 1460 | nM | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 10.59 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 5623.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6007 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 13448.1 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 5904.1 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 33491.5 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 18504.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16640 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16492 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16930.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5262 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13217.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2660.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10405.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2371 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3349.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 20762.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26603.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3757.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5353.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 22095 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18504.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 7562.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18995.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10499.1 | nM | PubChem BioAssay data set | ||
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 13217.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 9520.5 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 1.1 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 7497.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6740 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14830.4 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 5.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10590.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9357.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6682.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5955.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 353.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1310 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18833.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 16640 | nM | PubChem BioAssay data set | |
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 11780.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14698.5 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC149300 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9506 | High Similarity | NPC658 |
0.9506 | High Similarity | NPC95421 |
0.9506 | High Similarity | NPC198125 |
0.9506 | High Similarity | NPC197708 |
0.9494 | High Similarity | NPC141331 |
0.9494 | High Similarity | NPC318826 |
0.9494 | High Similarity | NPC114791 |
0.9494 | High Similarity | NPC210501 |
0.9494 | High Similarity | NPC104222 |
0.939 | High Similarity | NPC102851 |
0.939 | High Similarity | NPC5786 |
0.9341 | High Similarity | NPC80956 |
0.9325 | High Similarity | NPC473818 |
0.9317 | High Similarity | NPC285108 |
0.9317 | High Similarity | NPC33298 |
0.9313 | High Similarity | NPC289346 |
0.9308 | High Similarity | NPC172419 |
0.9308 | High Similarity | NPC238419 |
0.9245 | High Similarity | NPC239019 |
0.9245 | High Similarity | NPC247629 |
0.9198 | High Similarity | NPC90905 |
0.9198 | High Similarity | NPC4013 |
0.9187 | High Similarity | NPC1913 |
0.9181 | High Similarity | NPC260521 |
0.9181 | High Similarity | NPC469649 |
0.9172 | High Similarity | NPC8940 |
0.913 | High Similarity | NPC289811 |
0.913 | High Similarity | NPC160780 |
0.9128 | High Similarity | NPC240200 |
0.9128 | High Similarity | NPC142291 |
0.9128 | High Similarity | NPC158214 |
0.9128 | High Similarity | NPC7839 |
0.9128 | High Similarity | NPC290289 |
0.9128 | High Similarity | NPC223534 |
0.9112 | High Similarity | NPC471030 |
0.9107 | High Similarity | NPC297574 |
0.9107 | High Similarity | NPC472723 |
0.9102 | High Similarity | NPC163165 |
0.9075 | High Similarity | NPC160543 |
0.9075 | High Similarity | NPC472724 |
0.9075 | High Similarity | NPC469652 |
0.9075 | High Similarity | NPC93065 |
0.9075 | High Similarity | NPC472720 |
0.9075 | High Similarity | NPC472721 |
0.9075 | High Similarity | NPC187632 |
0.9075 | High Similarity | NPC31208 |
0.9074 | High Similarity | NPC476373 |
0.9074 | High Similarity | NPC239966 |
0.9074 | High Similarity | NPC166277 |
0.9074 | High Similarity | NPC203020 |
0.9074 | High Similarity | NPC119125 |
0.907 | High Similarity | NPC65489 |
0.907 | High Similarity | NPC475179 |
0.9068 | High Similarity | NPC133984 |
0.9057 | High Similarity | NPC16024 |
0.9057 | High Similarity | NPC3746 |
0.9057 | High Similarity | NPC44260 |
0.9057 | High Similarity | NPC61152 |
0.9057 | High Similarity | NPC205037 |
0.9042 | High Similarity | NPC100251 |
0.9024 | High Similarity | NPC227297 |
0.9023 | High Similarity | NPC40078 |
0.9023 | High Similarity | NPC97924 |
0.9023 | High Similarity | NPC471091 |
0.9018 | High Similarity | NPC472859 |
0.9018 | High Similarity | NPC25389 |
0.9018 | High Similarity | NPC311803 |
0.9017 | High Similarity | NPC173872 |
0.9017 | High Similarity | NPC269046 |
0.9017 | High Similarity | NPC119094 |
0.9012 | High Similarity | NPC74319 |
0.9012 | High Similarity | NPC469650 |
0.9012 | High Similarity | NPC474093 |
0.9012 | High Similarity | NPC261623 |
0.9012 | High Similarity | NPC111490 |
0.9012 | High Similarity | NPC104910 |
0.9012 | High Similarity | NPC287872 |
0.9006 | High Similarity | NPC123259 |
0.9006 | High Similarity | NPC129533 |
0.9006 | High Similarity | NPC97119 |
0.9006 | High Similarity | NPC135831 |
0.9006 | High Similarity | NPC297503 |
0.8994 | High Similarity | NPC79736 |
0.8994 | High Similarity | NPC67629 |
0.8988 | High Similarity | NPC98583 |
0.8988 | High Similarity | NPC172033 |
0.8988 | High Similarity | NPC175230 |
0.8988 | High Similarity | NPC88560 |
0.8982 | High Similarity | NPC204937 |
0.8982 | High Similarity | NPC149011 |
0.8976 | High Similarity | NPC261411 |
0.8976 | High Similarity | NPC190204 |
0.8976 | High Similarity | NPC43918 |
0.8963 | High Similarity | NPC476372 |
0.8963 | High Similarity | NPC476371 |
0.896 | High Similarity | NPC237202 |
0.8953 | High Similarity | NPC231254 |
0.8951 | High Similarity | NPC472860 |
0.8941 | High Similarity | NPC267549 |
0.8938 | High Similarity | NPC310661 |
0.8938 | High Similarity | NPC105827 |
0.8935 | High Similarity | NPC84482 |
0.8935 | High Similarity | NPC169645 |
0.8929 | High Similarity | NPC65333 |
0.892 | High Similarity | NPC476358 |
0.8909 | High Similarity | NPC121290 |
0.8908 | High Similarity | NPC477083 |
0.8908 | High Similarity | NPC477081 |
0.8896 | High Similarity | NPC87317 |
0.8895 | High Similarity | NPC470718 |
0.8895 | High Similarity | NPC35924 |
0.8895 | High Similarity | NPC199172 |
0.8889 | High Similarity | NPC291948 |
0.8889 | High Similarity | NPC300845 |
0.8889 | High Similarity | NPC318432 |
0.8889 | High Similarity | NPC88803 |
0.8889 | High Similarity | NPC250436 |
0.8889 | High Similarity | NPC104983 |
0.8882 | High Similarity | NPC472991 |
0.8882 | High Similarity | NPC191046 |
0.8882 | High Similarity | NPC194095 |
0.8882 | High Similarity | NPC469888 |
0.8882 | High Similarity | NPC472992 |
0.8882 | High Similarity | NPC327032 |
0.8876 | High Similarity | NPC472993 |
0.8876 | High Similarity | NPC473550 |
0.8869 | High Similarity | NPC47521 |
0.8869 | High Similarity | NPC476365 |
0.8862 | High Similarity | NPC311389 |
0.8862 | High Similarity | NPC128403 |
0.8862 | High Similarity | NPC470271 |
0.8857 | High Similarity | NPC201814 |
0.8855 | High Similarity | NPC142614 |
0.8851 | High Similarity | NPC72554 |
0.8851 | High Similarity | NPC97817 |
0.8851 | High Similarity | NPC30011 |
0.8848 | High Similarity | NPC148273 |
0.8844 | High Similarity | NPC470713 |
0.8844 | High Similarity | NPC21359 |
0.8844 | High Similarity | NPC470717 |
0.8844 | High Similarity | NPC25946 |
0.8844 | High Similarity | NPC470720 |
0.8844 | High Similarity | NPC460984 |
0.8841 | High Similarity | NPC53889 |
0.8841 | High Similarity | NPC24164 |
0.8837 | High Similarity | NPC117668 |
0.8837 | High Similarity | NPC469371 |
0.8834 | High Similarity | NPC114179 |
0.8834 | High Similarity | NPC156818 |
0.8834 | High Similarity | NPC68324 |
0.8834 | High Similarity | NPC160512 |
0.8834 | High Similarity | NPC289322 |
0.8834 | High Similarity | NPC38779 |
0.883 | High Similarity | NPC113836 |
0.883 | High Similarity | NPC476620 |
0.883 | High Similarity | NPC196127 |
0.883 | High Similarity | NPC37668 |
0.883 | High Similarity | NPC476622 |
0.883 | High Similarity | NPC476618 |
0.883 | High Similarity | NPC476623 |
0.883 | High Similarity | NPC267680 |
0.883 | High Similarity | NPC293626 |
0.883 | High Similarity | NPC476619 |
0.883 | High Similarity | NPC253521 |
0.883 | High Similarity | NPC258044 |
0.883 | High Similarity | NPC217387 |
0.883 | High Similarity | NPC476621 |
0.882 | High Similarity | NPC3474 |
0.882 | High Similarity | NPC189312 |
0.8817 | High Similarity | NPC67134 |
0.8817 | High Similarity | NPC47140 |
0.8814 | High Similarity | NPC477082 |
0.8807 | High Similarity | NPC264302 |
0.8805 | High Similarity | NPC92117 |
0.8802 | High Similarity | NPC175793 |
0.8793 | High Similarity | NPC295625 |
0.8793 | High Similarity | NPC473554 |
0.8793 | High Similarity | NPC470719 |
0.8786 | High Similarity | NPC162394 |
0.8786 | High Similarity | NPC241781 |
0.8786 | High Similarity | NPC156785 |
0.8773 | High Similarity | NPC134925 |
0.8773 | High Similarity | NPC471405 |
0.8772 | High Similarity | NPC61904 |
0.8772 | High Similarity | NPC144097 |
0.8765 | High Similarity | NPC166674 |
0.8765 | High Similarity | NPC219600 |
0.8765 | High Similarity | NPC46640 |
0.8765 | High Similarity | NPC34436 |
0.8765 | High Similarity | NPC263119 |
0.8758 | High Similarity | NPC36130 |
0.8758 | High Similarity | NPC134905 |
0.8757 | High Similarity | NPC181778 |
0.8757 | High Similarity | NPC470272 |
0.875 | High Similarity | NPC116745 |
0.8742 | High Similarity | NPC142528 |
0.8742 | High Similarity | NPC248257 |
0.8742 | High Similarity | NPC120621 |
0.8736 | High Similarity | NPC275977 |
0.8736 | High Similarity | NPC223860 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC149300 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8889 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8817 | High Similarity | NPD7993 | Clinical (unspecified phase) |
0.8647 | High Similarity | NPD7472 | Approved |
0.8588 | High Similarity | NPD7054 | Approved |
0.8538 | High Similarity | NPD7074 | Phase 3 |
0.8497 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8497 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8439 | Intermediate Similarity | NPD7251 | Discontinued |
0.8421 | Intermediate Similarity | NPD3818 | Discontinued |
0.8382 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8229 | Intermediate Similarity | NPD7685 | Pre-registration |
0.8204 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8198 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8198 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8198 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8166 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8136 | Intermediate Similarity | NPD8313 | Approved |
0.8136 | Intermediate Similarity | NPD8312 | Approved |
0.8121 | Intermediate Similarity | NPD1653 | Approved |
0.8111 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.8103 | Intermediate Similarity | NPD7228 | Approved |
0.8061 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8057 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8036 | Intermediate Similarity | NPD1934 | Approved |
0.7988 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7955 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7907 | Intermediate Similarity | NPD6234 | Discontinued |
0.7882 | Intermediate Similarity | NPD2801 | Approved |
0.7882 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7862 | Intermediate Similarity | NPD230 | Phase 1 |
0.7845 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7836 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7791 | Intermediate Similarity | NPD3882 | Suspended |
0.7772 | Intermediate Similarity | NPD8151 | Discontinued |
0.7771 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7758 | Intermediate Similarity | NPD6190 | Approved |
0.7746 | Intermediate Similarity | NPD7075 | Discontinued |
0.773 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD7266 | Discontinued |
0.7722 | Intermediate Similarity | NPD7240 | Approved |
0.7722 | Intermediate Similarity | NPD6559 | Discontinued |
0.7719 | Intermediate Similarity | NPD37 | Approved |
0.7714 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7688 | Intermediate Similarity | NPD4965 | Approved |
0.7688 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7688 | Intermediate Similarity | NPD4966 | Approved |
0.7684 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.767 | Intermediate Similarity | NPD6232 | Discontinued |
0.7665 | Intermediate Similarity | NPD1511 | Approved |
0.764 | Intermediate Similarity | NPD7473 | Discontinued |
0.7627 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7614 | Intermediate Similarity | NPD6959 | Discontinued |
0.7602 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7586 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7574 | Intermediate Similarity | NPD1512 | Approved |
0.7572 | Intermediate Similarity | NPD7819 | Suspended |
0.7572 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7558 | Intermediate Similarity | NPD7411 | Suspended |
0.7529 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD5402 | Approved |
0.7458 | Intermediate Similarity | NPD5494 | Approved |
0.7443 | Intermediate Similarity | NPD3749 | Approved |
0.7429 | Intermediate Similarity | NPD5353 | Approved |
0.7403 | Intermediate Similarity | NPD3751 | Discontinued |
0.7381 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7374 | Intermediate Similarity | NPD3787 | Discontinued |
0.7365 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7353 | Intermediate Similarity | NPD6799 | Approved |
0.7341 | Intermediate Similarity | NPD7458 | Discontinued |
0.7337 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7337 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7333 | Intermediate Similarity | NPD7680 | Approved |
0.7326 | Intermediate Similarity | NPD5403 | Approved |
0.7314 | Intermediate Similarity | NPD6801 | Discontinued |
0.7306 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7305 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7278 | Intermediate Similarity | NPD3750 | Approved |
0.7256 | Intermediate Similarity | NPD1613 | Approved |
0.7256 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7245 | Intermediate Similarity | NPD7435 | Discontinued |
0.7239 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD8127 | Discontinued |
0.7219 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD447 | Suspended |
0.7212 | Intermediate Similarity | NPD1933 | Approved |
0.7209 | Intermediate Similarity | NPD5401 | Approved |
0.7209 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7208 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7178 | Intermediate Similarity | NPD3027 | Phase 3 |
0.716 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD9494 | Approved |
0.7143 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7128 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7117 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD7874 | Approved |
0.711 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.711 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7102 | Intermediate Similarity | NPD6599 | Discontinued |
0.71 | Intermediate Similarity | NPD7585 | Approved |
0.7092 | Intermediate Similarity | NPD6779 | Approved |
0.7092 | Intermediate Similarity | NPD6776 | Approved |
0.7092 | Intermediate Similarity | NPD6777 | Approved |
0.7092 | Intermediate Similarity | NPD6782 | Approved |
0.7092 | Intermediate Similarity | NPD6781 | Approved |
0.7092 | Intermediate Similarity | NPD6780 | Approved |
0.7092 | Intermediate Similarity | NPD6778 | Approved |
0.7083 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7076 | Intermediate Similarity | NPD8166 | Discontinued |
0.7071 | Intermediate Similarity | NPD7697 | Approved |
0.7071 | Intermediate Similarity | NPD7698 | Approved |
0.7071 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7062 | Intermediate Similarity | NPD6386 | Approved |
0.7062 | Intermediate Similarity | NPD6385 | Approved |
0.7059 | Intermediate Similarity | NPD7039 | Approved |
0.7059 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD7038 | Approved |
0.705 | Intermediate Similarity | NPD7583 | Approved |
0.7049 | Intermediate Similarity | NPD5242 | Approved |
0.7041 | Intermediate Similarity | NPD2796 | Approved |
0.7025 | Intermediate Similarity | NPD9268 | Approved |
0.7024 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7017 | Intermediate Similarity | NPD919 | Approved |
0.7015 | Intermediate Similarity | NPD7701 | Phase 2 |
0.6988 | Remote Similarity | NPD6233 | Phase 2 |
0.6982 | Remote Similarity | NPD3748 | Approved |
0.6977 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD8434 | Phase 2 |
0.6957 | Remote Similarity | NPD3926 | Phase 2 |
0.695 | Remote Similarity | NPD8320 | Phase 1 |
0.695 | Remote Similarity | NPD8319 | Approved |
0.6949 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6946 | Remote Similarity | NPD943 | Approved |
0.6939 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6938 | Remote Similarity | NPD8155 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD6823 | Phase 2 |
0.6931 | Remote Similarity | NPD7549 | Discontinued |
0.6919 | Remote Similarity | NPD6674 | Discontinued |
0.6914 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD2533 | Approved |
0.6914 | Remote Similarity | NPD2532 | Approved |
0.6914 | Remote Similarity | NPD2534 | Approved |
0.6912 | Remote Similarity | NPD7801 | Approved |
0.6904 | Remote Similarity | NPD7700 | Phase 2 |
0.6904 | Remote Similarity | NPD7699 | Phase 2 |
0.6881 | Remote Similarity | NPD7584 | Approved |
0.6875 | Remote Similarity | NPD6273 | Approved |
0.6875 | Remote Similarity | NPD8150 | Discontinued |
0.6857 | Remote Similarity | NPD7390 | Discontinued |
0.6854 | Remote Similarity | NPD3226 | Approved |
0.6845 | Remote Similarity | NPD1240 | Approved |
0.6842 | Remote Similarity | NPD2935 | Discontinued |
0.6837 | Remote Similarity | NPD6535 | Approved |
0.6837 | Remote Similarity | NPD6534 | Approved |
0.6829 | Remote Similarity | NPD1203 | Approved |
0.6826 | Remote Similarity | NPD6798 | Discontinued |
0.6826 | Remote Similarity | NPD3764 | Approved |
0.6811 | Remote Similarity | NPD7229 | Phase 3 |
0.6807 | Remote Similarity | NPD6832 | Phase 2 |
0.6807 | Remote Similarity | NPD4908 | Phase 1 |
0.68 | Remote Similarity | NPD7440 | Discontinued |
0.679 | Remote Similarity | NPD1091 | Approved |
0.6778 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD6971 | Discontinued |
0.6768 | Remote Similarity | NPD3225 | Approved |
0.6765 | Remote Similarity | NPD1607 | Approved |
0.6757 | Remote Similarity | NPD1247 | Approved |
0.675 | Remote Similarity | NPD9545 | Approved |
0.675 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD6100 | Approved |
0.6744 | Remote Similarity | NPD6099 | Approved |
0.6742 | Remote Similarity | NPD920 | Approved |
0.6737 | Remote Similarity | NPD5953 | Discontinued |
0.6726 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6724 | Remote Similarity | NPD1652 | Phase 2 |
0.6723 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6723 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.672 | Remote Similarity | NPD7286 | Phase 2 |
0.6706 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.6686 | Remote Similarity | NPD7003 | Approved |
0.6667 | Remote Similarity | NPD4357 | Discontinued |
0.6667 | Remote Similarity | NPD7177 | Discontinued |
0.6667 | Remote Similarity | NPD3455 | Phase 2 |
0.6646 | Remote Similarity | NPD1608 | Approved |
0.6633 | Remote Similarity | NPD4287 | Approved |
0.6629 | Remote Similarity | NPD1243 | Approved |
0.6616 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6616 | Remote Similarity | NPD6213 | Phase 3 |
0.6616 | Remote Similarity | NPD6212 | Phase 3 |
0.661 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6608 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6608 | Remote Similarity | NPD6355 | Discontinued |
0.6608 | Remote Similarity | NPD5124 | Phase 1 |
0.6591 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6591 | Remote Similarity | NPD4110 | Phase 3 |
0.659 | Remote Similarity | NPD4308 | Phase 3 |
PubChem CID   | 16129778 |
ChEMBL   | CHEMBL506247 |
ZINC   |
Molecular Weight:   | 1700.17 |
ALogP:   | -12.6304 |
MLogP:   | 4.76 |
XLogP:   | 2.662 |
# Rotatable Bonds:   | 56 |
Polar Surface Area:   | 777.98 |
# H-Bond Aceptor:   | 16 |
# H-Bond Donor:   | 25 |
# Rings:   | 11 |
# Heavy Atoms:   | 122 |